Fiscal 2022 ER!!!There is someting that I don't understand.
From a shareholders deficit in 2021 ($479557) to a positive shareholders $194201.
And they didn't were expecting a reimboursement of $300millions from EPCOT, but only almost $148millions. AND they spent almost $110 millions of cost od reorganisation....!!!!
Wow, and now they want to liquidate this company at a ridiculous price.
They have a good balance sheet and a decent cash flow.
May be someone can explain to me how those people can see them into a mirror??
And I will look about the 1st Q report.
Consolidated balance sheets As at March 31 (in thousands of U.S. dollars) As of March 31, Notes 2022 2021 ASSETS Current assets Cash and cash equivalents $ 125,755 $ 171,761 Restricted cash 2,736 905 Trade and other receivables, net 7(a) 308,941 270,538 Securitization proceeds receivable from ERCOT 7(d) 147,500 — Gas in storage 3,313 2,379 Derivative instruments 13 538,700 18,382 Income taxes recoverable 11,774 6,551 Other current assets 8(a) 131,570 129,944 Total current assets 1,270,289 600,460 Non-current assets Investments 9 — 26,154 Property and equipment, net 10 6,505 14,177 Intangible assets, net 12 43,815 56,240 Goodwill 12 130,945 130,235 Derivative instruments 13 133,014 8,429 Deferred income taxes 18 198 2,977 Other non-current assets 8(b) 39,048 28,042 Total non-current assets 353,525 266,254 TOTAL ASSETS $ 1,623,814 $ 866,714 LIABILITIES Current liabilities Trade and other payables 14 $ 349,923 $ 310,114 Deferred revenue 695 1,119 Income taxes payable 2,370 3,281 Derivative instruments 13 13,170 11,115 Provisions — 5,396 Current portion of long-term debt 16 126,289 103,215 Total current liabilities 492,447 434,240 Liabilities subject to compromise 14, 15, 16 845,890 854,984 Non-current liabilities Long-term debt 16 130 1,240 Derivative instruments 13 12,916 48,643 Deferred income taxes 18 75,792 2,186 Other non-current liabilities 2,438 4,978 Total non-current liabilities 91,276 57,047 TOTAL LIABILITIES $ 1,429,613 $ 1,346,271 Commitments and contingencies 25 SHAREHOLDERS’ EQUITY Common shares, no par value; unlimited shares authorized at March 31, 2022 and March 31, 2021; 48,078,637 shares issued and outstanding at March 31, 2022; 48,078,637 shares issued and outstanding at March 31, 2021 19 $ 1,168,162 $ 1,168,162 Contributed deficit (12,073) (13,558) Accumulated deficit (1,088,119) (1,766,646) Accumulated other comprehensive income 126,527 132,797 Non-controlling interest (296) (312) TOTAL SHAREHOLDERS’ EQUITY 194,201 (479,557) TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 1,623,814 $ 866,714